Lawyers USA has ceased publication. If you have purchased a research pass or still have additional time on your current Digital Subscription, you may access locked stories by logging in.
Studies spur FDA review of Yaz, other contraceptives
Safety review based on studies linking newer pills to higher blood clot risk
The Food and Drug Administration is conducting a safety review of birth control pills that contain drospirenone, such as Yaz, Yasmin, Beyaz and Ocella, after recent studies linked the drugs to a higher incidence of blood clots.